All In MedTech

Device Trial Radar · NCT02910414

TARGET BP I Clinical Trial

A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects With Hypertension

Last checked: Nov 20, 2026Latest source record: Oct 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingTitle says "pivotal". Randomized with 300 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

300

Actual

Start

Jul 22, 2019

Primary completion

Dec 2023

Study completion May 2026

Sponsor

Lead sponsor
Ablative Solutions, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 22, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure controlled trial, comparing renal denervation performed with the Peregrine System Kit in the treatment group to the sham control group (without renal denervation - no alcohol infusion). Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central randomization.

Conditions

  • Hypertension

Interventions

  • Dehydrated alcoholDrug

    Dehydrated Alcohol Injection, USP is used in the study.

  • Peregrine System Kit (Sham Procedure)Device

    Pre-procedural diagnostic renal angiography only, performed for confirmation of anatomical eligibility prior to randomization

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in mean systolic ABPMTime frame: 3 months

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Cardiology PC

    Birmingham, Alabama

  • Piedmont Heart Institute

    Atlanta, Georgia

  • NC Heart and Vascular Research

    Raleigh, North Carolina

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.